JP2013531684A5 - - Google Patents

Download PDF

Info

Publication number
JP2013531684A5
JP2013531684A5 JP2013519035A JP2013519035A JP2013531684A5 JP 2013531684 A5 JP2013531684 A5 JP 2013531684A5 JP 2013519035 A JP2013519035 A JP 2013519035A JP 2013519035 A JP2013519035 A JP 2013519035A JP 2013531684 A5 JP2013531684 A5 JP 2013531684A5
Authority
JP
Japan
Prior art keywords
phenyl
imidazo
pyridin
cyclobutylamine
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013519035A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013531684A (ja
JP5830094B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2011/061508 external-priority patent/WO2012007345A2/en
Publication of JP2013531684A publication Critical patent/JP2013531684A/ja
Publication of JP2013531684A5 publication Critical patent/JP2013531684A5/ja
Application granted granted Critical
Publication of JP5830094B2 publication Critical patent/JP5830094B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013519035A 2010-07-12 2011-07-07 置換イミダゾ[1,2−a]ピリミジンおよび−ピリジン Expired - Fee Related JP5830094B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP10169205 2010-07-12
EP10169205.1 2010-07-12
US39277910P 2010-10-13 2010-10-13
US61/392,779 2010-10-13
PCT/EP2011/061508 WO2012007345A2 (en) 2010-07-12 2011-07-07 Substituted imidazo[1,2-a]pyrimidines and -pyridines

Publications (3)

Publication Number Publication Date
JP2013531684A JP2013531684A (ja) 2013-08-08
JP2013531684A5 true JP2013531684A5 (OSRAM) 2014-08-21
JP5830094B2 JP5830094B2 (ja) 2015-12-09

Family

ID=44532777

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013519035A Expired - Fee Related JP5830094B2 (ja) 2010-07-12 2011-07-07 置換イミダゾ[1,2−a]ピリミジンおよび−ピリジン

Country Status (10)

Country Link
US (1) US8975265B2 (OSRAM)
EP (1) EP2593451B1 (OSRAM)
JP (1) JP5830094B2 (OSRAM)
CN (1) CN103097384B (OSRAM)
AR (1) AR090005A1 (OSRAM)
CA (1) CA2804845A1 (OSRAM)
ES (1) ES2552841T3 (OSRAM)
TW (1) TW201206933A (OSRAM)
UY (1) UY33503A (OSRAM)
WO (1) WO2012007345A2 (OSRAM)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY163187A (en) * 2011-04-06 2017-08-15 Taiho Pharmaceutical Co Ltd Novel imidazo-oxazine compound or salt thereof
PT2694510E (pt) * 2011-04-07 2016-02-08 Bayer Pharma AG Imidazopiridazinas como inibidores da akt quinase
US9370517B2 (en) * 2012-01-10 2016-06-21 Bayer Intellectual Property Gmbh Substituted pyrazolopyrimidines as Akt kinase inhibitors
WO2013104610A1 (en) * 2012-01-10 2013-07-18 Bayer Intellectual Property Gmbh Substituted imidazopyrazines as akt kinase inhibitors
BR112015000675B1 (pt) * 2012-07-13 2022-07-12 UCB Biopharma SRL Derivados de imidazopiridina como moduladores da atividade de tnf
US9527835B2 (en) 2014-02-13 2016-12-27 Incyte Corporation Cyclopropylamines as LSD1 inhibitors
DK3105226T3 (da) 2014-02-13 2019-10-14 Incyte Corp Cyclopropylaminer som lsd1-inhibitorer
PT3105218T (pt) 2014-02-13 2019-12-05 Incyte Corp Ciclopropilaminas como inibidores de lsd1
EP3105219B9 (en) 2014-02-13 2018-10-03 Incyte Corporation Cyclopropylamines as lsd1 inhibitors
WO2015154064A2 (en) 2014-04-04 2015-10-08 Del Mar Pharmaceuticals Use of dianhydrogalactitol and analogs or derivatives thereof to treat non-small-cell carcinoma of the lung and ovarian cancer
TWI687419B (zh) 2014-07-10 2020-03-11 美商英塞特公司 作為lsd1抑制劑之咪唑并吡啶及咪唑并吡嗪
WO2016007722A1 (en) 2014-07-10 2016-01-14 Incyte Corporation Triazolopyridines and triazolopyrazines as lsd1 inhibitors
US9758523B2 (en) 2014-07-10 2017-09-12 Incyte Corporation Triazolopyridines and triazolopyrazines as LSD1 inhibitors
TW201613925A (en) 2014-07-10 2016-04-16 Incyte Corp Imidazopyrazines as LSD1 inhibitors
ES2772682T3 (es) 2015-02-27 2020-07-08 Taiho Pharmaceutical Co Ltd Cristal de imidazooxazina, composición farmacéutica que contiene dicho cristal, y método de producción de dicho cristal
EP3626720A1 (en) 2015-04-03 2020-03-25 Incyte Corporation Heterocyclic compounds as lsd1 inhibitors
CN106188063A (zh) * 2015-05-08 2016-12-07 中国科学院上海药物研究所 用作Lp-PLA2抑制剂的双环类化合物、其制备方法及医药用途
KR102710120B1 (ko) 2015-08-12 2024-09-27 인사이트 홀딩스 코포레이션 Lsd1 저해제의 염
US11883404B2 (en) 2016-03-04 2024-01-30 Taiho Pharmaceuticals Co., Ltd. Preparation and composition for treatment of malignant tumors
PE20190377A1 (es) 2016-04-22 2019-03-08 Incyte Corp Formulaciones de un inhibidor de lsd 1
WO2018013430A2 (en) 2016-07-12 2018-01-18 Arisan Therapeutics Inc. Heterocyclic compounds for the treatment of arenavirus infection
KR20190043437A (ko) 2017-10-18 2019-04-26 씨제이헬스케어 주식회사 단백질 키나제 억제제로서의 헤테로고리 화합물
GB201811695D0 (en) * 2018-07-17 2018-08-29 Salvensis Compounds for use in the treatment of fascioliasis
US10968200B2 (en) 2018-08-31 2021-04-06 Incyte Corporation Salts of an LSD1 inhibitor and processes for preparing the same
KR102195348B1 (ko) 2018-11-15 2020-12-24 에이치케이이노엔 주식회사 단백질 키나제 억제제로서의 신규 화합물 및 이를 포함하는 약제학적 조성물
US12419865B2 (en) 2018-12-06 2025-09-23 Arisan Therapeutics Inc. Compounds for the treatment of arenavirus infection
CN109734713B (zh) * 2019-03-07 2021-06-04 东华理工大学 一种3-亚胺基咪唑并[1,2-a]吡啶化合物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1898903T3 (pl) * 2005-06-10 2013-08-30 Merck Sharp & Dohme Inhibitory aktywności Akt
AR064010A1 (es) 2006-12-06 2009-03-04 Merck & Co Inc Inhibidores de la actividad de la akt
WO2009021990A1 (en) 2007-08-14 2009-02-19 Bayer Schering Pharma Aktiengesellschaft Fused imidazoles for cancer treatment
CN102015686B (zh) 2008-03-21 2014-07-02 诺华股份有限公司 杂环化合物及其用途
US8207169B2 (en) * 2008-06-03 2012-06-26 Msd K.K. Substituted [1,2,4]triazolo[4′,3′:1,6]pyrido[2,3-b]pyrazines of the formula D
WO2010088177A1 (en) 2009-02-02 2010-08-05 Merck Sharp & Dohme Corp. Inhibitors of akt activity
US8168652B2 (en) 2009-03-12 2012-05-01 Merck Sharp & Dohme Corp. Inhibitors of AKT activity
WO2010114780A1 (en) 2009-04-01 2010-10-07 Merck Sharp & Dohme Corp. Inhibitors of akt activity
EP2473495A1 (en) 2009-09-18 2012-07-11 Almac Discovery Limited Pharmaceutical compounds
GB0919380D0 (en) 2009-11-04 2009-12-23 Almac Discovery Ltd Pharmaceutical compouds

Similar Documents

Publication Publication Date Title
JP2013531684A5 (OSRAM)
JP6770127B2 (ja) Btk阻害薬としての一級カルボキサミド類
US11485745B2 (en) Amido spirocyclic amide and sulfonamide derivatives
EP3630770B1 (en) Pyrazolo[3,4-b]pyrazine derivatives as shp2 phosphatase inhibitors
KR101959590B1 (ko) c-KIT 키나제 억제제로서의 화합물 및 조성물
US20240245681A1 (en) Heterocyclic derivatives useful as shp2 inhibitors
TWI429434B (zh) 作為受體酪胺酸激酶抑制劑之咪唑并〔1,2-a〕吡啶化合物
AU2009278442B2 (en) Imidazopyridin-2-one Derivatives
JP7654071B2 (ja) 複素環スピロ化合物及び使用方法
JP5830094B2 (ja) 置換イミダゾ[1,2−a]ピリミジンおよび−ピリジン
KR20080026654A (ko) 헤테로시클릭 야누스 키나제 3 억제제
TWI731317B (zh) 原肌球蛋白相關之激酶(trk)抑制劑
JP2010523576A5 (OSRAM)
JP2020189863A (ja) 核内受容体調節剤
MX2015004151A (es) Inhibidores del factor de diferenciacion de crecimiento-8 (gdf-8).
KR20170132323A (ko) 이미다졸로닐 퀴놀린 및 atm 키나아제 저해제로서의 이의 용도
KR20180030199A (ko) 콜로니 자극 인자-1 수용체(csf-1r) 저해제
CA3160307A1 (en) Substituted 1,5-naphthyridines or quinolines as alk5 inhibitors
JP7426486B2 (ja) インターフェロン遺伝子刺激因子(sting)のモジュレーターとしての複素環式化合物
JP2020502252A (ja) Dyrk1aおよび/またはdyrk1bキナーゼの阻害剤としてのキノリンの誘導体
CN114341125A (zh) Trex1调节剂
TW202233174A (zh) 肽基精胺酸去亞胺酶之抑制劑
AU2024263032A1 (en) Mrgprx2 inhibitors and methods of use thereof
NZ734594A (en) Bicyclic heterocycles as fgfr4 inhibitors